Our open innovation strategy is designed to promote change beyond GSK by sharing expertise, resources intellectual property and know-how with external researchers and the scientific community in Australia and across the globe.
We have an open innovation approach focused on diseases of the developing world, such as malaria, tuberculosis and parasitic infections and we are already adapting open innovation models to apply to other areas of great medical need and scientific challenge including infectious and rare diseases.
We are partnering with Australian academics in Melbourne on immunology and researchers at Sydney University in malaria and TB.
Do you have an idea? Then share it with us by visiting innovation.gsk.com.